Medical News

RSS

Specific type of neurons determine frightening stimulus reaction: Research

Fear can make you run, it can make you fight, and it can glue you to the spot. Scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy and GlaxoSmithKline in Verona, Italy, have identified not only the part of the brain but the specific type of neurons that determine how mice react to a frightening stimulus.

26 Aug 2010

Bankers Healthcare Group ranks 1839th on 2010 Inc. 500/5000 America's fastest-growing organizations list

Bankers Healthcare Group, one of the nation's leaders in financing for healthcare professionals, is pleased to announce that they have been recognized once again on the 2010 Inc. 500/5000 list as one of America's fastest-growing organizations. BHG has earned the 1839th list position among 5000 selected companies.

26 Aug 2010

UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

UNC Hospitals has received the American College of Cardiology Foundation's NCDR ACTION Registry-GWTG Silver Performance Achievement Award for 2010 - one of only 26 hospitals nationwide to do so.

26 Aug 2010

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.

26 Aug 2010

Critical mechanistic link between mutant protein and disease pathogenesis in ALS uncovered

New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder. The study, published by Cell Press in the August 26th issue of the journal Neuron, describes a critical mechanistic link between a mutant protein and disease pathogenesis in an animal model of amyotrophic lateral sclerosis (ALS).

26 Aug 2010

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Researchers from North Carolina State University have developed extremely small microneedles that can be used to deliver medically-relevant nanoscale dyes called quantum dots into skin - an advance that opens the door to new techniques for diagnosing and treating a variety of medical conditions, including skin cancer.

26 Aug 2010

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.

26 Aug 2010

Worldwide conference to discuss increase in autism, help restore health

The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.

26 Aug 2010

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement -- which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research -- came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

26 Aug 2010

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.

26 Aug 2010

EHE International endorses lifestyle medicine competencies

EHE International, a nationally recognized leader in preventive medicine, has endorsed the recently released set of physician competencies for prescribing lifestyle medicine. These competencies, suggested for primary care physicians, exemplify what EHE International has always practiced and encouraged.

26 Aug 2010

Lockheed Martin awarded contracts to accelerate advancement of Nationwide Health Information Network

Lockheed Martin will take steps to accelerate the advancement of digital health records and secure health information exchanges with two new agreements to support the Nationwide Health Information Network. The contracts, which were awarded by the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC), total $9 million over two years.

26 Aug 2010

Supplementing diet with broccoli, plantain fibres prevents relapse of Crohn's disease: Study

Plantain and broccoli fibres may block a key stage in the development of the inflammatory bowel disorder, Crohn's disease, suggests preliminary research published online in Gut.

26 Aug 2010

Rep. Gerry Connolly sees strong shift in public view of health reform

Kaiser Health News staff writer Mary Agnes Carey talks with first term Rep. Gerry Connolly, D-Va., who says the health care debate has changed dramatically since the combative town hall meetings of last August when some protesters across the country said passage of sweeping overhaul legislation would amount to a government takeover of the health care system (Carey, 8/25).

26 Aug 2010

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will enroll a total of 16 long-term, or chronic, spinal cord injury patients, with an American Spinal Injury Association (ASIA) Grade A level of impairment, one-to-two years post-injury.

26 Aug 2010

Developing specific liver cell lines from stem cells holds promise for new liver disease treatment: Researchers

By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.

26 Aug 2010

Type 2 diabetes, insulin resistance increases risk for Alzheimer's disease: Research

People with insulin resistance and type 2 diabetes appear to be at an increased risk of developing plaques in the brain that are associated with Alzheimer's disease, according to new research published in the August 25, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

26 Aug 2010

Atherotech Diagnostics to exhibit VAP Cholesterol Test at NLA Summer 2010 Clinical Update

Atherotech Diagnostics Lab will exhibit its VAP Cholesterol Test in booth 105 at the National Lipid Association (NLA) Summer 2010 Clinical Lipid Update.

26 Aug 2010

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.

26 Aug 2010

IPS explores why some advocates say women-focused MDGs are missing the mark

"A month ahead of the 2010 Millennium Development Goals (MDGs) review summit at the United Nations, some women's groups are voicing concern that member states' commitment to women's issues is insufficient and slowing progress towards gender parity worldwide," Inter Press Service reports in an article that examines progress towards reaching women-centered MDGs.

26 Aug 2010

Medical News

Specific type of neurons determine frightening stimulus reaction: Research

Bankers Healthcare Group ranks 1839th on 2010 Inc. 500/5000 America's fastest-growing organizations list

UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Critical mechanistic link between mutant protein and disease pathogenesis in ALS uncovered

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Worldwide conference to discuss increase in autism, help restore health

NIH suspends funding new embryonic stem cell research following court order

Phase 1 CRLX101 clinical study paves way for promising innovations in cancer therapy: Cerulean Pharma

EHE International endorses lifestyle medicine competencies

Lockheed Martin awarded contracts to accelerate advancement of Nationwide Health Information Network

Supplementing diet with broccoli, plantain fibres prevents relapse of Crohn's disease: Study

Rep. Gerry Connolly sees strong shift in public view of health reform

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

Developing specific liver cell lines from stem cells holds promise for new liver disease treatment: Researchers

Type 2 diabetes, insulin resistance increases risk for Alzheimer's disease: Research

Atherotech Diagnostics to exhibit VAP Cholesterol Test at NLA Summer 2010 Clinical Update

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

IPS explores why some advocates say women-focused MDGs are missing the mark

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News